Literature DB >> 25990439

Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats.

Irena Kasacka1, Żaneta Piotrowska2, Izabela Janiuk3.   

Abstract

Arterial hypertension is associated with serious dysfunction of the cardiovascular system and digestive system. Given the relevant role of vasoactive intestinal peptide (VIP) in the regulation of digestion process, control of blood pressure and heart rate as well as cardio- and gastro-protective character of the peptide, it appeared worthwhile to undertake the research aimed at immunohistochemical identification and evaluation of VIP-positive structures in the pylorus and heart of hypertensive rats. Up to now, this issue has not been investigated. The experimental model of hypertension in rats according to Goldblatt (two-kidney one clip model of hypertension) was used in the study. The experimental material (pylorus and heart) was collected in the sixth week of the study. VIP-containing structures were evaluated using immunohistochemical and morphometric methods. The analysis of the results showed a significant increase in the number of immunoreactive VIP structures and in the intensity of immunohistochemical staining in the stomach and in the heart of hypertensive rats. Our findings indicate that VIP is an important regulator of cardiovascular and digestive system in physiological and pathological conditions. However, to better understand the exact role of VIP in hypertension further studies need to be carried out.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Vasoactive intestinal peptide; heart; immunohistochemistry; rat; renovascular hypertension; stomach

Mesh:

Substances:

Year:  2015        PMID: 25990439      PMCID: PMC4935291          DOI: 10.1177/1535370215587533

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  39 in total

Review 1.  The taming of immunohistochemistry: the new era of quality control.

Authors:  G E Herman; E A Elfont
Journal:  Biotech Histochem       Date:  1991       Impact factor: 1.718

Review 2.  VIP modulation of immune cell functions.

Authors:  M De la Fuente; M Delgado; R P Gomariz
Journal:  Adv Neuroimmunol       Date:  1996

3.  Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection.

Authors:  D K Das; R Kalfin; N Maulik; R M Engelman
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

4.  Gene Deletion of VIP Leads to Increased Mortality Associated with Progressive Right Ventricular Hypertrophy.

Authors:  Anthony M Szema; Sayyed A Hamidi
Journal:  J Cardiovasc Dis       Date:  2014-04-01

5.  Effect of vasoactive intestinal peptide on gastric secretion in the cat.

Authors:  M Vagne; S J Konturek; J A Chayvialle
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

6.  Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.

Authors:  Fabian Halleck; Katharina Schröder; Sven Holleck-Weithmann; Peter Kossmehl; Reinhold Kreutz; Lars Rothermund
Journal:  Clin Exp Hypertens       Date:  2014-03-28       Impact factor: 1.749

7.  Vasoactive intestinal peptide, a singlet oxygen quencher.

Authors:  B R Misra; H P Misra
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

8.  Effects of vasoactive intestinal peptide (VIP) on contractile responses of smooth muscle in rat stomach.

Authors:  T Ohta; S Ito; A Ohga
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

9.  Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum.

Authors:  M Fujimiya; H Yamamoto; A Kuwahara
Journal:  Am J Physiol       Date:  1998-10

10.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.

Authors:  M Delgado; C Martinez; D Pozo; J R Calvo; J Leceta; D Ganea; R P Gomariz
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  5 in total

1.  Functional and structural changes in aorta of mice divergently selected for basal metabolic rate.

Authors:  Diana Sawicka; Sebastian Maciak; Hanna Kozłowska; Irena Kasacka; Monika Kloza; Anna Sadowska; Emilia Sokołowska; Marek Konarzewski; Halina Car
Journal:  J Comp Physiol B       Date:  2019-12-23       Impact factor: 2.200

2.  Long non-coding RNA and mRNA analysis of Ang II-induced neuronal dysfunction.

Authors:  Lin-Lin Shao; Yue-Hua Jiang; Ling-Yu Jiang; Chuan-Hua Yang; Ying-Zi Qi
Journal:  Mol Biol Rep       Date:  2019-04-03       Impact factor: 2.316

3.  Effect of Kvass on Improving Functional Dyspepsia in Rats.

Authors:  Zhanmei Shao; Jidong Zhong; Yuming Fang; Yongqiang Ma
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

4.  Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.

Authors:  Dongdong Fu; Soulixay Senouthai; Junjie Wang; Yanwu You
Journal:  BMC Nephrol       Date:  2019-09-05       Impact factor: 2.388

5.  1-Deoxynojirimycin (DNJ) Ameliorates Indomethacin-Induced Gastric Ulcer in Mice by Affecting NF-kappaB Signaling Pathway.

Authors:  Xuehua Piao; Shuangdi Li; Xiaodan Sui; Lianyi Guo; Xingmei Liu; Hongmei Li; Leming Gao; Shusheng Cai; Yanrong Li; Tingting Wang; Baohai Liu
Journal:  Front Pharmacol       Date:  2018-04-19       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.